Justin George Varghese
Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.
Twitter handle: @jeffmason1
Britain's Informa is in talks about a deal to buy events organizer UBM for more than 3 billion pounds ($4.14 billion), rekindling plans from almost a decade ago to create a major business media and conventions group.
Expectations that Mediclinic International Plc would succeed in taking over Britain's Spire Healthcare Group fell on Thursday after South Africa's largest private hospital group said no deal had been reached.
Britain's Spire Healthcare has rejected a full takeover offer from South African private hospitals operator Mediclinic International , which already owns nearly 30 percent of its stock, sending its shares up 12 percent.
Medical technology company ConvaTec Group Plc on Monday slashed its full-year organic revenue growth forecast after supply issues hurt its third quarter, wiping off a fifth of its market value.
British conglomerate Smiths Group reported a fall in underlying full-year revenue due to weakness in its energy equipment and service business as well as its medical device unit.
British outsourcing company Mitie Group may cut up to 480 jobs as it overhauls its cleaning and engineering divisions, and said the cost of its turnaround would be higher than expected.
Indivior's U.S. subsidiary has filed lawsuits against firms seeking approval for generic versions of its opioid addiction treatment Suboxone, which generates 80 percent of the drugmaker's revenue.
Spire Healthcare Group Plc , Britain's second-largest healthcare firm, said first-half profit slumped 75 percent, hurt by legal settlement charges, sending its shares down as much as 25 percent on Thursday morning.
British drugmaker Vectura reported a doubling in first-half losses and warned full-year revenues would be hit by customers running down stocks of asthma inhaler Flutiform, sending its shares as much as 14 percent lower on Wednesday.
Shares in London-listed Indivior plunged 40 percent after the drugmaker said a U.S. court ruling could clear the way for a generic rival to its treatment for opioid addiction that generates 80 percent of its revenues.